Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Amplitude Vascular Systems
AddedFeb 17, 2024
UpdatedJun 18, 2026
Amplitude Vascular Systems

Amplitude Vascular Systems

Series B

AVS, founded in 2018, is a medical device company dedicated to treating severe arterial disease.

HQ
Ann Arbor, MI, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Amplitude Vascular Systems (AVS), founded in 2018 by Hitinder Gurm, M.D., and Robert Chisena, Ph.D., is a medical device company dedicated to treating severe arterial disease. The company's core mission is to redefine interventional therapy for severely calcified lesions. AVS offers the PULSE IVL™ System, which utilizes pressure waves to shatter intravascular calcium and expand lesions to restore blood flow. Their market focus is on providing innovative solutions for patients suffering from severely calcified arterial disease.

Notable affiliated individuals include co-founders Hitinder Gurm, an Interventional Cardiologist and Chief Clinical Officer at the University of Michigan, and Robert Chisena, a Ph.D. with significant expertise in medical technology. AVS has attracted attention for its groundbreaking PULSE IVL™ System, which has shown promising results in clinical settings. The company’s impact lies in its potential to significantly improve outcomes for patients with severe arterial calcification, offering a safer and more effective treatment option.

Amplitude Vascular Systems - Similar Companies

Evident Vascular logo

Evident Vascular

Avinger logo

Avinger

avinger.com

Access Vascular logo

Access Vascular

FastWave Medical logo

FastWave Medical

Traverse Vascular logo

Traverse Vascular

Euphrates Vascular logo

Euphrates Vascular

PolyVascular logo

PolyVascular

polyvascular.com

SonoVascular logo

SonoVascular

sonovascular.com

Pulsar Vascular logo

Pulsar Vascular

Attwill Vascular Technologies logo

Attwill Vascular Technologies

Bluegrass Vascular Technologies logo

Bluegrass Vascular Technologies

Micro Medical Solutions logo

Micro Medical Solutions

Avenu Medical logo

Avenu Medical

avenumedical.com

Alucent Biomedical logo

Alucent Biomedical

alucentmedical.com

Avicena logo

Avicena

avicenaheart.com

Amplitude Vascular Systems - Quick Facts

Who are Amplitude Vascular Systems' competitors?

Companies similar to Amplitude Vascular Systems include Evident Vascular, Avinger, Access Vascular and FastWave Medical.

When was Amplitude Vascular Systems founded?

Amplitude Vascular Systems was founded in 2020.

Where is Amplitude Vascular Systems' headquarters located?

Amplitude Vascular Systems' headquarters is located in Ann Arbor, MI, US.

When was Amplitude Vascular Systems' last funding round?

Amplitude Vascular Systems' most recent funding round was for $8.8M (USD) in April 2023.

How much has Amplitude Vascular Systems raised to-date?

As of Apr 4, 2023, Amplitude Vascular Systems has raised a total of $30M (USD).

How many employees does Amplitude Vascular Systems have?

Amplitude Vascular Systems has 20 employees as of Feb 5, 2024.

Amplitude Vascular Systems - Classification

Ownership
  • Venture Capital
Technology
  • HealthTech
Revenue
  • Recurring
Main Product
  • Medical Devices
Tags
  • Hardware
  • Medical
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified